Eosinophil apoptosis induced by fungal immunomodulatory peptide-fve via reducing IL-5α receptor

Journal of the Formosan Medical Association

Volumn 106, Issue 1, 2007, Pages 36-43

  Hsieh, Chia Wei ^a   Lan, Joung Liang ^a   Meng, Qiu ^a   Cheng, Ya Wen ^a   Huang, Huei Mei ^b   Tsai, Jaw Ji ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Eosinophils; FIP; Fungal immunomodulatory peptide

Indexed keywords

ANNEXIN; FAS ANTIGEN; FUNGAL IMMUNOMODULATORY PEPTIDE FVE PROTEIN; FUNGAL PROTEIN; INTERLEUKIN 5; MESSENGER RNA; PROCASPASE 3; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN FIP FVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DENSITY GRADIENT; DOWN REGULATION; EOSINOPHIL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 33846852451     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60214-X     Document Type: Article

References (32)

1. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213-340.
2. Barnes PJ. Pathophysiology of asthma. Br J Clin Pharmacol 1996;42:3-10.
3. Tsai JJ, Kao MH, Han SH. The respiratory burst activity of activated eosinophils in atopic asthmatics. Int Arch Allergy Immunol 1999;119:38-44.
4. Huang J, Olivenstein R, Taha R, et al. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Resp Crit Care Med 1999;160:725-9.
5. Flood-Page P, Phipps S, Menzies-Gow A, et al. Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. J Invest Dermatol 2004;122:1406-12.
6. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997;97:701-9.
7. Simon HU. Eosinophil apoptosis in allergic diseases-an emerging new issue. Clin Exp Allergy 1998;28: 1321-4.
8. Lecki MJ, Ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatics response. Lancet 2000;356:2144-8.
9. Foster PS, Mould AW, Yang M, et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001;179:173-81.
10. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-56.
11. Meagher LC, Cousin JM, Seckl JR, et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156:4422-8.
12. Alam R, Forsythe P, Stafford S, et al. Transforming growth factor-beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994; 179:1041-5.
13. Wedi B, Raap U, Lewrick H, et al. IL-4-induced apoptosis in peripheral blood eosinophils. J Allergy Clin Immunol 1998;102:1013-20.
14. Walsh GM, Williamson ML, Symon FA, et al. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with GM-CSF. Blood 1996;87:2815-21.
15. Matsumoto K, Schleimer RP, Saito H, et al. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995;86:1437-43.
16. Druilhe A, Cai ZX, Haile S, et al. Fas-mediated apoptosis in cultured human eosinophils. Blood 1996;87:2822-30.
17. Paaventhan P, Joseph JS, Seow SV, et al. A 1.7 Å structure of Fve, a member of the new fungal immunomodulatory protein family. J Mol Biol 2003;332:461-70.
18. Hsieh KY, Hsu CI, Lin JY, et al. Oral administration of an edible-mushroom-derived protein inhibits the development of food-allergic reactions in mice. Clin Exp Allergy 2003; 33:1595-602.
19. Tsai JJ, Shen HD, Chua KY. Purification of group 2 Dermatophagoides pteronyssinus allergen and prevalence of its specific IgE in asthmatics. Int Arch Allergy Immunol 2000;121:205-10.
20. Seow SV, Kuo IC, Paaventhan P, et al. Crystallization and preliminary X-ray crystallographic studies on the fungal immunomodulatory protein Fve from the golden needle mushroom (Flammulina velutipes). Acta Crystallogr D Biol Crystallogr 2003;59:1487-9.
21. Meng Q, Ying S, Corrigan CJ, et al. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and survival. Allergy 1997;52: 1095-101.
22. Phelps M, Wilkins BS, Jones DB. Selective genetic analysis of p53 immunostain-positive cells. Mol Pathol 2000;53: 159-61.
23. Santeliz JV, Nest GV, Traquina P, et al. Amb a 1-linked CpG oligodeoxynu Amb a 1-inked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002;109:455-62.
24. Phelps M, Wilkins BS, Jones DB. Selective genetic analysis of p53 immunostain-positive cells. Mol Pathol 2000;53: 159-61.
25. Yamaguchi Y, Suda T, Ohta S, et al. Analysis of the survival of mature human eosinophils. Blood 1991;78:1592-7.
26. Dibbert B, Daigle I, Braun D, et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 1998;92:778-83.
27. Her E, Austen, KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991;88:1982-7.
28. Virchow JC Jr, Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergy provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
29. Luttmann W, Opfer A, Dauer E, et al. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils. Eur J Immunol 1998;28:2057-65.
30. Liu LY, Sedgwick JB, Bates ME, et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J Immunol 2002;169:6459-66.
31. Yoshimura-Uchiyama C, Yamaguchi M, Nagase H, et al. Changing expression of IL-3 and IL-5 receptors in cultured human eosinophils. Biochem Biophys Res Commun 2003; 309:26-31.
32. Yousefi S, Hoessli DC, Blaser K, et al. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996;183: 1407-14.